PROCEPT BioRobotics
Develops robotic-assisted systems for the minimally invasive treatment of prostate diseases.
What they do
PROCEPT BioRobotics develops the AquaBeam Robotic System, which delivers Aquablation therapy for the treatment of benign prostatic hyperplasia. Urology clinics and hospitals purchase this system to provide automated, heat-free tissue removal, aiming to deliver predictable and consistent outcomes for patients with prostate enlargement.
The record
- Vertical
- Devices & Robotics
- Sub-segment
- Surgical robotics
- Product type
- Device
- Stage
- Public
- Headquarters
- Redwood City, USA
- Region
- North America
- Founded
- 2009
- Total funding
- $170M raised
Notable investors: Sutter Hill Ventures, Fidelity Management, T. Rowe Price, CPMG.